Top Tweets for #Signateralooksdeeper
Exciting news! Signatera is the Winner of Medical Device Innovation award by @FierceBiotech and @FiercePharma's @LifeSciEvents Innovation Awards.
https://t.co/6PZOIkOF5a #FierceLifeSciencesAwards #SignateraLooksDeeper
Serial #ctDNA analysis can elevate patient care and positively impact treatment decisions.
New findings published in @CCR_AACR show how Natera’s #Signatera test can provide essential knowledge for #ColorectalCancer patients. #SignateraLooksDeeper https://t.co/JpjDA7Ace6
Largest MRD-guided study to date in colorectal cancer at the 2021 ESMO GI Congress! #WorldGI2021 #SignateraLooksDeeper https://t.co/JVe6VUc1PP
Great article in Barron's about how Natera is leading the field of MRD testing and why its tumor-informed approach is so critical. #SignateraLooksDeeper https://t.co/j47OjhmhUb
Dr. Charles Cha of The Cancer Institute at @HartfordHealthC’s Saint Vincent’s Medical Center explains the benefits of Signatera's tumor-informed approach & how the breakthrough test is changing lives of #cancer patients: https://t.co/weeBFuAWad
#SignateraLooksDeeper
Read more about the groundbreaking IMvigor010 study results published in @Nature last week in this @GenomeWeb article.
#Oncology #ctDNA #Immunotherapy #BladderCancer #SignateraLooksDeeper
https://t.co/BBa8Apb7j9
Discover how Signatera, a personalized blood test, can be used to better assess response to #immunotherapy and identify cancer progression.
Learn more: https://t.co/JmUUB3Uxrh
#SignateraLooksDeeper #ctDNA #Cancer https://t.co/lyotq7I8zm
We're proud to announce that the Centers for Medicare & Medicaid Services (CMS) has granted ADLT status for our Signatera MRD test!
Read more: https://t.co/HfkbZtDNAc
#SignateraLooksDeeper #Oncology #ctDNA
Imvigor010 Signatera ctDNA data published today in @Nature. Huge step forward in the MRD field. Follow on Imvigor011 study now enrolling. Many thanks to all involved especially @tompowles1 and @genentech. $ntra #ctdna #mibc #adjuvant https://t.co/tB0idbcsn5
Hear first-hand from our CEO Steve Chapman about where Natera is headed, and which markets we’re bringing our #cfDNA testing to. #SignateraLooksDeeper #biotech
.@NateraGenetics CEO Steve Chapman joins @JillMalandrino on @Nasdaq #TradeTalks to discuss cell-free DNA diagnostic testing and remote testing capabilities. $NTRA
https://t.co/dTPEXj3eWN
One 78-year-old patient, whose immunotherapy for bladder #cancer was monitored with Signatera, is now able to get back to living after getting the “all clear” from @azzi because #SignateraLooksDeeper.
Discover more of Signatera’s capabilities on @NPR. https://t.co/KYwimuR0sE
We're proud to have presented a large body of evidence for Signatera at 2021 ASCO Annual Meeting. Learn more about the posters presented here: https://t.co/udDU4niylC
#ASCO21 #SignateraLooksDeeper #CRCSM #Oncology #ColorectalCancer #MRD #PrecisionOncology
Check out our poster looking at stage III CRC patients and the clinical utility of ctDNA to help guide decision-making: https://t.co/udDU4niylC
#ASCO21 #SignateraLooksDeeper #CRCSM #Oncology #ColorectalCancer #MRD #PrecisionOncology
Going to the 2021 ASCO Annual Meeting? Stop by Natera's booth to learn about the latest exciting research surrounding a tumor-informed approach for ultra sensitive #MRD detection in various solid tumors: https://t.co/udDU4niylC
#ASCO21 #SignateraLooksDeeper #CRCSM #Oncology
Join us as Alexey Aleshin, MD demonstrates how a tumor-informed approach trumps a tumor-naive approach when is comes to patient monitoring and recurrence detection: https://t.co/udDU4niylC
#ASCO21 #SignateraLooksDeeper #CRCSM #Oncology #ColorectalCancer #MRD #PrecisiOnoncology
We are excited to present additional data on the use of Signatera to detect #MRD in colorectal and hepatobiliary cancer and multiple myeloma. Learn more: https://t.co/udDU4niylC
#ASCO21 #SignateraLooksDeeper #CRCSM #oncology #colorectalancer #precisiononcology
Check out our latest press release to read about important new research on #MRD Natera is presenting at the 2021 ASCO annual meeting!
Learn more about our #ASCO21 presentations and #AACR21 too: https://t.co/Ee7UAl03NH
#SignateraLooksDeeper #ColorectalCancer #MultipleMyeloma
Join an engaging discussion as we review how a tumor-informed approach may be used for MRD detection and monitoring to help illuminate the treatment pathway for cancer patients in the adjuvant setting.
Register now: https://t.co/eVRH6QBG2h
#SignateraLooksDeeper #GDUGI2021
Don't miss Natera's 4 poster presentations at #ASCO21, featuring new data in #colorectalcancer and #multiplemyeloma!
#SignateraLooksDeeper #tumorinformed https://t.co/NapyKJESHb
#ASCO21 is just a few weeks away! Check out our latest press release for a sneak peek of the 4 posters we'll be presenting featuring groundbreaking new data from the CIRCULATE-Japan trial.
Read more: https://t.co/zPcYIRCVtF
#SignateraLooksDeeper #multiplemyeloma #CRCSM
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers